SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-16-010074
Filing Date
2016-11-14
Accepted
2016-11-14 17:30:33
Documents
5
Period of Report
2016-11-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc_8kcsoannouncement11-14.htm 8-K 53944
2 EX-10.1 bpmc_ex101marion-employmen.htm EX-10.1 98499
3 EX-10.2 bpmc_ex102christoph-firsta.htm EX-10.2 31302
4 EX-99.1 bpmc_ex991pressrelease.htm EX-99.1 17920
5 GRAPHIC bpmcex991pressrelease001.jpg GRAPHIC 22797
  Complete submission text file 0001558370-16-010074.txt   234436
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 161996159
SIC: 2834 Pharmaceutical Preparations